share_log

McDonald's | PX14A6G: Notice of exempt solicitation

McDonald's | PX14A6G: Notice of exempt solicitation

麦当劳 | PX14A6G:豁免招标通知
美股sec公告 ·  04/18 14:27
Moomoo AI 已提取核心信息
The Shareholder Commons, Inc. has submitted a proposal urging shareholders to vote in favor of Item 6 at the upcoming McDonald's Corporation Annual Meeting on May 22, 2024. The proposal calls for McDonald's to adopt an enterprise-wide policy to phase out the use of medically-important antibiotics for disease prevention in its beef and pork supply chains. This initiative aligns with WHO guidelines and aims to mitigate the risks posed by antimicrobial resistance (AMR) to public health and the economy. McDonald's, being the largest beef purchaser in the U.S. and a major pork buyer, has significant influence on market practices. The company opposes the proposal, claiming it is unnecessary, duplicative, and would not benefit shareholders. However, The Shareholder...Show More
The Shareholder Commons, Inc. has submitted a proposal urging shareholders to vote in favor of Item 6 at the upcoming McDonald's Corporation Annual Meeting on May 22, 2024. The proposal calls for McDonald's to adopt an enterprise-wide policy to phase out the use of medically-important antibiotics for disease prevention in its beef and pork supply chains. This initiative aligns with WHO guidelines and aims to mitigate the risks posed by antimicrobial resistance (AMR) to public health and the economy. McDonald's, being the largest beef purchaser in the U.S. and a major pork buyer, has significant influence on market practices. The company opposes the proposal, claiming it is unnecessary, duplicative, and would not benefit shareholders. However, The Shareholder Commons refutes these claims, highlighting the systemic threat of AMR, which could cost the global economy $100 trillion by 2050. They argue that McDonald's current policies do not sufficiently address the risks and that the company has failed to meet its own antibiotic use reduction commitments. The Shareholder Commons emphasizes the importance of considering the broader economic impact and the health of diversified investment portfolios, rather than focusing solely on McDonald's financial performance.
股东下议院已提交一份提案,敦促股东在即将于2024年5月22日举行的麦当劳公司年会上对第6项投赞成票。该提案要求麦当劳采取一项全企业政策,逐步停止在其牛肉和猪肉供应链中使用具有重要医学意义的抗生素来预防疾病。该举措符合世卫组织的指导方针,旨在减轻抗微生物药物耐药性(AMR)对公共卫生和经济构成的风险。麦当劳是美国最大的牛肉购买者和主要的猪肉买家,对市场惯例具有重大影响。该公司反对该提案,声称该提案没有必要,是重复的,不会使股东受益。但是,股东下议院驳斥了这些说法,强调了抗微生物药物耐药性的系统性威胁,到2050年,抗微生物药物耐药性可能使全球经济损失100万亿美元。他们认为,麦当劳目前的政策不足以应对风险,而且该公司未能兑现自己的减少抗生素使用的承诺。股东下议院强调必须考虑更广泛的经济影响和多元化投资组合的健康状况,而不是只关注麦当劳的财务业绩。
股东下议院已提交一份提案,敦促股东在即将于2024年5月22日举行的麦当劳公司年会上对第6项投赞成票。该提案要求麦当劳采取一项全企业政策,逐步停止在其牛肉和猪肉供应链中使用具有重要医学意义的抗生素来预防疾病。该举措符合世卫组织的指导方针,旨在减轻抗微生物药物耐药性(AMR)对公共卫生和经济构成的风险。麦当劳是美国最大的牛肉购买者和主要的猪肉买家,对市场惯例具有重大影响。该公司反对该提案,声称该提案没有必要,是重复的,不会使股东受益。但是,股东下议院驳斥了这些说法,强调了抗微生物药物耐药性的系统性威胁,到2050年,抗微生物药物耐药性可能使全球经济损失100万亿美元。他们认为,麦当劳目前的政策不足以应对风险,而且该公司未能兑现自己的减少抗生素使用的承诺。股东下议院强调必须考虑更广泛的经济影响和多元化投资组合的健康状况,而不是只关注麦当劳的财务业绩。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息